Chemical acylation of an acquired serine suppresses oncogenic signaling of K-Ras(G12S)
Ziyang Zhang(Howard Hughes Medical Institute), Kevan M. Shokat(Howard Hughes Medical Institute)
Cited by 146
Related Papers
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
|PLoS Biology|2009|1.1k
A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy
|Cancer Cell|2022|129
KRAS is vulnerable to reversible switch-II pocket engagement in cells
|Nature Chemical Biology|2022|104
A Small Molecule Reacts with the p53 Somatic Mutant Y220C to Rescue Wild-type Thermal Stability
|Cancer Discovery|2022|94
Brain-restricted mTOR inhibition with binary pharmacology
|Nature|2022|83